Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ATRS - Antares Pharma Q3 2021 Earnings Preview

ATRS - Antares Pharma Q3 2021 Earnings Preview

Antares Pharma Inc.
Antares Pharma (NASDAQ:ATRS) is scheduled to announce Q3 earnings results on Thursday, November 4th, before market open. The consensus EPS Estimate is $0.03 and the consensus Revenue Estimate is $47.93M (+19.8% Y/Y). The company reported second-quarter revenue and profit that beat Wall Street estimates and reiterated its financial forecast for the year, in August. Recently, Antares Pharma initiated a Phase 1 study for ATRS-1902 for adrenal crisis rescue. Over the last 3 months, EPS estimates have seen 0 upward revisions and 4 downward. Revenue estimates have seen 1 upward revision and 6 downward. The company's shares have fallen more than 7% year to date.

For further details see:

Antares Pharma Q3 2021 Earnings Preview
Stock Information
Company Name: Antares Pharma Inc.
Stock Symbol: ATRS
Market: NASDAQ
Website: antarespharma.com
Menu
ATRS ATRS Quote ATRS Short ATRS News ATRS Articles ATRS Message Board
Get ATRS Alerts

News, Short Squeeze, Breakout and More Instantly...